title: SKRIFTLIG FORESPØRGSEL nr. 3835/96 af José GARCÍA-MARGALLO Y MARFIL til Kommissionen. EU-investeringer i Latinamerika - Det Forenede Kongeriges investeringer i Mexico

eurovoc_concepts:
EU investment
European Union
Latin America
Mexico
United Kingdom
direct investment


title: PREGUNTA ESCRITA n. 3819/96 del José GARCÍA-MARGALLO Y MARFIL a la Comisión. Inversiones de la UE en América Latina: cifras de Italia en Mercosur

eurovoc_concepts:
EU investment
European Union
Italy
Latin America
Mercosur countries
direct investment


title: SCHRIFTLICHE ANFRAGE Nr. 3819/96 von José GARCÍA-MARGALLO Y MARFIL an die Kommission. Investitionen der EU in Lateinamerika: Zahlen über italienische Investitionen im Mercosur


title: Commission Regulation (EC) No 17/97 of 8 January 1997 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

eurovoc_concepts:
animal product
food inspection
health control
veterinary drug
waste

text: L_1997005EN. 01001201. xml 9. 1. 1997    EN Official Journal of the European Communities L 5/12 COMMISSION REGULATION (EC) No 17/97 of 8 January 1997 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 2034/96 (2) and in particular Articles 6, 7 and 8 thereof, Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be established progressively for all pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals; Whereas maximum residue limits should be established only after the examination within the Committee for Veterinary Medicinal Products of all the relevant information concerning the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs; Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue); Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum residue limits should usually be established for the target tissues of liver or kidney; whereas, however, the liver and kidney are frequently removed from carcasses moving in international trade, and maximum residue limits should therefore also always be established for muscle or fat tissues; Whereas, in the case of veterinary medicinal products intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey; Whereas, eprinomectin should be inserted into Annex I to Regulation (EEC) No 2377/90; Whereas zinc acetate, zinc chloride, zinc gluconate, zinc oleate, zinc stearate, chlorhexidine, glycerol formal, hesperidin, hesperidin methyl chalcone, menbutone and quatresin should be inserted into Annex II to Regulation (EEC) No 2377/90; Whereas, in order to allow for the completion of scientific studies, flumequine, doxycycline and albendazole sulfoxide should be inserted into Annex III to Regulation (EEC) No 2377/90; Whereas it appears that maximum residue limits cannot be established for chlorpromazine because residues, at whatever limit, in foodstuffs of animal origin constitute a hazard to the health of the consumer, whereas chlorpromazine should therefore be inserted into Annex IV to Regulation (EEC) No 2377/90; Whereas a period of 60 days should be allowed before the entry into force of this Regulation in order to allow Member States to make any adjustment which may be necessary to the authorisations to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/851/EEC (3), as last amended by Directive 93/40/EEC (4) to take account of the provisions of this Regulation; Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products, HAS ADOPTED THIS REGULATION: Article 1 Annexes I, II, III and IV of Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto. Article 2 This Regulation shall enter into force on the sixtieth day following its publication in the Official Journal of the European Communities. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 8 January 1997. For the Commission Martin BANGEMANN Member of the Commission (1)  OJ No L 224, 18. 8. 1990, p. 1. (2)  OJ No L 272, 25. 10. 1996, p. 2. (3)  OJ No L 317, 6. 11. 1981, p. 1. (4)  OJ No L 214, 24. 8. 1993, p. 31. ANNEX Regulation (EEC) No 2377/90 is modified as follows: A. Annex I is modified as follows: 2. Anti-parasitic agents 2. 3. Agents acting against endo- and ectoparasites 2. 3. 1. Avermectins Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions ‘2. 3. 1. 4. Eprinomectin Eprinomectin B1a Bovine 30 μg/kg Muscle   30 μg/kg Fat 600 μg/kg Liver 100 μg/kg Kidney 30 μg/kg Milk’ B. Annex II is modified as follows: 1. Inorganic chemicals Pharmacologically active substance(s) Animal Species Other provisions ‘1. 24. Zinc acetate All food producing species   1. 25. Zinc chloride All food producing species   1. 26. Zinc gluconate All food producing species   1. 27. Zinc oleate All food producing species   1. 28. Zinc stearate All food producing species’   2. Organic compounds Pharmacologically active substance(s) Animal Species Other provisions ‘2. 69. Chlorhexidine All food producing species For topical use only 2. 70. Glycerol formal All food producing species   2. 71. Hesperidin Equidae   2. 72. Hesperidin methyl chalcone Equidae   2. 73. Menbutone Bovine, ovine, caprine, porcine, equidae   2. 74. Quatresin All food producing species For use as preservative only at concentrations of up to 0,5 %’ C. Annex III is modified as follows: 1. Anti-infectious agents 1. 2. Antibiotics 1. 2. 6. Quinolones Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions ‘1. 2. 6. 4. Flumequine Flumequine Bovine, ovine, porcine, chicken 50 μg/kg Muscle, fat or fat/skin Provisional MRLs expire on 1. 1. 2000’ 100 μg/kg Liver 300 μg/kg Kidney Salmonidae 150 μg/kg Muscle/skin 1. 2. 8. Tetracyclines Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions ‘1. 2. 8. 1. Doxycycline Sum of parent drug and its 4-epimer Porcine, poultry 600 μg/kg Kidney Provisional MRLs expire on 1. 1. 1998’ 300 μg/kg Liver, skin/fat 100 μg/kg Muscle Bovine 600 μg/kg Kidney 300 μg/kg Liver 100 μg/kg Muscle 2. Antiparasitic agents 2. 1. Agents acting against endoparasites 2. 1. 1. Benzimidazoles and pro-benzimidazoles Pharmacologically active substance Marker residue Animal Species MRLs Target tissues Other provisions ‘2. 1. 1. 10. Albendazole sulphoxide Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole Bovine, ovine, pheasant 1 000 μg/kg Liver Provisional MRLs expire on 1. 1. 1998’ 500 μg/kg Kidney 100 μg/kg Muscle, fat Bovine, ovine 100 μg/kg Milk D. Annex IV is modified as follows: List of pharmacologically active substances for which no maximum levels can be fixed: ‘8. Chlorpromazine’


title: KOMMISSIONENS FÖRORDNING (EG) nr 15/97 av den 8 januari 1997 om fastställande av exportbidrag för vitsocker och råsocker som exporteras i obearbetat skick

eurovoc_concepts:
beet sugar
cane sugar
export refund
raw sugar
white sugar


title: Commission Recommendation of 8 January 1997 concerning a coordinated programme for the official control of foodstuffs for 1997

eurovoc_concepts:
EU law
allergy
aromatic plant
consumer information
food inspection
public health

formats: html pdfa1b print


title: INTERROGAZIONE SCRITTA n. 3800/96 dell'on. José GARCÍA- MARGALLO Y MARFIL alla Commissione. Investimenti UE in America latina: investimenti della Francia in Messico

eurovoc_concepts:
EU investment
European Union
France
Latin America
Mexico
direct investment


title: PERGUNTA ESCRITA n. 3850/96 do Deputado José GARCÍA- MARGALLO Y MARFIL à Comissão. Cooperação da UE na América Latina: volume das ajudas da Alemanha ao Mercosul

eurovoc_concepts:
European Union
Germany
Latin America
Mercosur countries
development aid
international cooperation


title: WRITTEN QUESTION No. 3822/96 by José GARCÍA-MARGALLO Y MARFIL to the Commission. EU investments in Latin America: figures for Luxembourg's investments in Brazil

eurovoc_concepts:
Brazil
Central America
EU investment
European Union
Luxembourg
direct investment


title: SKRIFTLIG FORESPØRGSEL nr. 3829/96 af José GARCÍA-MARGALLO Y MARFIL til Kommissionen. EU-investeringer i Latinamerika - Nederlandenes investeringer i MERCOSUR

eurovoc_concepts:
EU investment
European Union
Latin America
Mercosur countries
Netherlands
direct investment


title: PREGUNTA ESCRITA n. 3817/96 del José GARCÍA-MARGALLO Y MARFIL a la Comisión. Inversiones de la UE en América Latina: cifras de Italia en Brasil

eurovoc_concepts:
Brazil
EU investment
European Union
Italy
Latin America
direct investment


title: QUESTION ECRITE no 3875/96 de José GARCÍA-MARGALLO Y MARFIL à la Commission. Coopération UE/Amérique latine: aide de la Finlande en faveur du Mercosur

eurovoc_concepts:
European Union
Finland
Latin America
Mercosur countries
development aid
international cooperation


title: SCHRIFTELIJKE VRAAG nr. 3826/96 van José GARCÍA-MARGALLO Y MARFIL aan de Commissie. Investeringen van de EU in Latijns- Amerika: investeringscijfers van Nederland in de afzonderlijke Middenamerikaanse landen

eurovoc_concepts:
Central America
EU investment
European Union
Latin America
Netherlands
direct investment


title: INTERROGAZIONE SCRITTA n. 3825/96 dell'on. José GARCÍA- MARGALLO Y MARFIL alla Commissione. Investimenti UE in America latina: investimenti dei Paesi Bassi in Messico

eurovoc_concepts:
EU investment
European Union
Latin America
Mexico
Netherlands
direct investment